Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,830,000 | 4,338,000 | 5,534,000 | 4,184,000 | 5,714,000 |
| Marketable Securities | 75,000 | 69,000 | 66,000 | 81,000 | 184,000 |
| Inventories | 4,716,000 | 4,231,000 | 3,900,000 | 3,969,000 | 3,873,000 |
| Other current assets | 5,659,000 | 5,751,000 | 5,727,000 | 5,457,000 | 6,055,000 |
| TOTAL | $16,587,000 | $14,678,000 | $15,227,000 | $13,692,000 | $16,167,000 |
| Non-Current Assets | |||||
| PPE Net | 9,668,000 | 9,052,000 | 8,872,000 | 8,776,000 | 8,748,000 |
| Intangibles | 21,834,000 | 12,044,000 | 13,488,000 | 14,520,000 | 11,556,000 |
| Other Non-Current Assets | 5,357,000 | 4,877,000 | 4,499,000 | 4,487,000 | 4,609,000 |
| TOTAL | $36,859,000 | $25,973,000 | $26,859,000 | $27,783,000 | $24,913,000 |
| Total Assets | $53,446,000 | $40,651,000 | $42,086,000 | $41,475,000 | $41,080,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,285,000 | 2,915,000 | 2,762,000 | 3,604,000 | 2,698,000 |
| Accounts payable and accrued liabilities | 3,120,000 | 2,790,000 | 2,739,000 | 2,666,000 | 2,568,000 |
| TOTAL | $13,417,000 | $13,295,000 | $13,677,000 | $13,815,000 | $15,010,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,277,000 | 15,784,000 | 15,403,000 | 14,622,000 | 12,203,000 |
| Other Non-Current Liabilities | 10,541,000 | 5,461,000 | 3,633,000 | 4,301,000 | 3,423,000 |
| TOTAL | $31,151,000 | $22,420,000 | $20,597,000 | $20,913,000 | $17,243,000 |
| Total Liabilities | $44,568,000 | $35,715,000 | $34,274,000 | $34,728,000 | $32,253,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,340,000 | 1,339,000 | 1,336,000 | 1,349,000 | 1,387,000 |
| Retained earnings | -1,397,000 | -2,074,000 | 913,000 | 652,000 | 3,370,000 |
| Other shareholders' equity | 2,340,000 | 2,239,000 | 2,153,000 | 1,787,000 | 1,602,000 |
| TOTAL | $5,114,000 | $4,263,000 | $6,997,000 | $5,810,000 | $8,032,000 |
| Total Liabilities And Equity | $49,682,000 | $39,978,000 | $41,271,000 | $40,538,000 | $40,285,000 |